4//SEC Filing
Dachille Douglas A. 4
Accession 0000899243-21-034292
CIK 0001743881other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 5:15 PM ET
Size
5.4 KB
Accession
0000899243-21-034292
Insider Transaction Report
Form 4
Dachille Douglas A.
Director
Transactions
- Award
Stock Option (right to buy)
2021-08-17+49,869→ 49,869 totalExercise: $49.54Exp: 2031-08-16→ Common Stock (49,869 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001652908
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 5:15 PM ET
- Size
- 5.4 KB